Details for 2021191120

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATION AUS EINEM IL-4R-ANTAGONISTEN, EINEM KORTIKOSTEROID UND EINEM LANG WIRKENDEN BETA2-ADRENERGEN AGONISTEN ZUR BEHANDLUNG VON ASTHMA

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021191120

EP Publication Number

3973987

E-Number

1648378

Language

PCT Number

Publication Date

30.03.2022 A

10.01.2024 B1

Registration Date

10.01.2024

AT Publication Date

15.01.2024

Application Date

20.02.2015

Registration Number

Priorities

21.02.2014

201461943019 P

15.09.2014

14306413

10.11.2014

201462077669 P

IPC

A61K 39/395 20060101AFI20220224BHEP

Maximum Duration of Protection

20.02.2035

Owner

Sanofi Biotechnology82 Avenue Raspail 94250 GentillyFR

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591-6707US

Representative

No representatives present

Inventor

PIROZZI, Gianluca Bridgewater, 08807US

SKOBIERANDA, Franck Flourtown, 19031US

LI, Yongtao Bridgewater, 08807US

GRAHAM, Neil Tarrytown, 10591-6707US

WEINSTEIN, Steven P. Tarrytown, 10591-6707US

Information about Fees